Current Therapy of Drugs in Amyotrophic Lateral Sclerosis

被引：38

作者：

Lu, Haiyan ^{[1
]}

Le, Wei Dong ^{[2
]}

Xie, Ya-Ying ^{[1
]}

Wang, Xiao-Ping ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Dept Neurol, Shanghai Peoples Hosp 1, Shanghai 200080, Peoples R China

[2] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA

来源：

CURRENT NEUROPHARMACOLOGY | 2016年 / 14卷 / 04期

基金：

中国国家自然科学基金;

关键词：

Amyotrophic lateral sclerosis; motor neuron disease; neurodegenerative disease; SOD1; mutations; riluzole; edaravone; pyrimethamine; TRANSGENIC MOUSE MODEL; DELAYS DISEASE ONSET; SUPEROXIDE-DISMUTASE; CEREBROSPINAL-FLUID; EXTENDS SURVIVAL; VALPROIC ACID; MUTANT SOD1; NEUROPROTECTIVE AGENTS; PROTEIN AGGREGATION; MOTOR-NEURONS;

D O I：

10.2174/1570159X14666160120152423

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Amyotrophic lateral sclerosis (ALS), commonly termed as motor neuron disease (MND) in UK, is a chronically lethal disorder among the neurodegenerative diseases, meanwhile. ALS is basically irreversible and progressive deterioration of upper and lower motor neurons in the motor cortex, brain stem and medulla spinalis. Riluzole, used for the treatment of ALS, was demonstrated to slightly delay the initiation of respiratory dysfunction and extend the median survival of patients by a few months. In this study, the key biochemical defects were discussed, such as: mutant Cu/Zn superoxide dismutase, mitochondrial protectants, and anti-excitotoxic/ anti-oxidative / anti-inflammatory/ anti-apoptotic agents, so the related drug candidates that have been studied in ALS models would possibly be further used in ALS patients.

引用

页码：314 / 321

页数：8

共 102 条

[1] Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial [J].

Aggarwal, Swati P. ;

Zinman, Lorne ;

Simpson, Elizabeth ;

McKinley, Jane ;

Jackson, Katherine E. ;

Pinto, Hanika ;

Kaufman, Petra ;

Conwit, Robin A. ;

Schoenfeld, David ;

Shefner, Jeremy ;

Cudkowicz, Merit .

LANCET NEUROLOGY, 2010, 9 (05) :481-488

[2] Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis [J].

Ahn, Suk-Won ;

Jeon, Gye Sun ;

Kim, Myung-Jin ;

Shon, Jee-Heun ;

Kim, Jee-Eun ;

Shin, Je-Young ;

Kim, Sung-Min ;

Kim, Seung Hyun ;

Ye, In-Hae ;

Lee, Kwang-Woo ;

Hong, Yoon-Ho ;

Sung, Jung-Joon .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 340 (1-2) :112-116

[3] Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis [J].

Battaglia, Giuseppe ;

Riozzi, Barbara ;

Bucci, Domenico ;

Di Menna, Luisa ;

Molinaro, Gemma ;

Pallottino, Simone ;

Nicoletti, Ferdinando ;

Bruno, Valeria .

NEUROBIOLOGY OF DISEASE, 2015, 74 :126-136

[4] A CONTROLLED TRIAL OF RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].

BENSIMON, G ;

LACOMBLEZ, L ;

MEININGER, V ;

BOUCHE, P ;

DELWAIDE, C ;

COURATIER, P ;

BLIN, O ;

VIADER, F ;

PEYROSTPAUL, H ;

DAVID, J ;

MALOTEAUX, JM ;

HUGON, J ;

LATERRE, EC ;

RASCOL, A ;

CLANET, M ;

VALLAT, JM ;

DUMAS, A ;

SERRATRICE, G ;

LECHEVALLIER, B ;

PEUCH, AJ ;

NGUYEN, T ;

SHU, C ;

BASTIEN, P ;

PAPILLON, C ;

DURRLEMAN, S ;

LOUVEL, E ;

GUILLET, P ;

LEDOUX, L ;

ORVOENFRIJA, E ;

DIB, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) :585-591

[5] Onset and progression in inherited ALS determined by motor neurons and microglia [J].

Boillee, Severine ;

Yamanaka, Koji ;

Lobsiger, Christian S. ;

Copeland, Neal G. ;

Jenkins, Nancy A. ;

Kassiotis, George ;

Kollias, George ;

Cleveland, Don W. .

SCIENCE, 2006, 312 (5778) :1389-1392

[6] Clinical and biological changes under treatment with lithium carbonate and valproic acid in sporadic amyotrophic lateral sclerosis [J].

Boll, Marie-Catherine ;

Bayliss, Leo ;

Vargas-Canas, Steven ;

Burgos, Jorge ;

Montes, Sergio ;

Penaloza-Solano, Guillermo ;

Rios, Camilo ;

Alcaraz-Zubeldia, Mireya .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 340 (1-2) :103-108

[7] Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis [J].

Bordet, Thierry ;

Buisson, Bruno ;

Michaud, Magali ;

Drouot, Cyrille ;

Galea, Pascale ;

Delaage, Pierre ;

Akentieva, Natalia P. ;

Evers, Alex S. ;

Covey, Douglas F. ;

Ostuni, Mariano A. ;

Lacapere, Jean-Jacques ;

Massaad, Charbel ;

Schumacher, Michael ;

Steidl, Esther-Marie ;

Maux, Delphine ;

Delaage, Michel ;

Henderson, Christopher E. ;

Pruss, Rebecca M. .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 322 (02) :709-720

[8] Riluzol as treatment of the amyotrophic lateral sclerosis [J].

Borrás-Blasco, J ;

Plaza-Macías, I ;

Navarro-Ruiz, A ;

Perís-Martí, J ;

Antón-Cano, A .

REVISTA DE NEUROLOGIA, 1998, 27 (160) :1021-1027

[9] Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis [J].

Brettschneider, Johannes ;

Widl, Karin ;

Schattauer, Dagmar ;

Ludolph, Albert C. ;

Tumani, Hayrettin .

NEUROSCIENCE LETTERS, 2007, 416 (03) :257-260

[10] Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells [J].

Carri, MT ;

Ferri, A ;

Battistoni, A ;

Famhy, L ;

Gabbianelli, R ;

Poccia, F ;

Rotilio, G .

FEBS LETTERS, 1997, 414 (02) :365-368

← 1 2 3 4 5 6 7 8 9 10 →